Harish Ramchandani

Managing Director

The Indian veterinary pharma­ceuticals market is experiencing significant growth, propelled by several key factors. With a rising trend in animal husbandry, farmers are in­creasingly turning to milk farming, poultry, and other livestock activities for higher profits and seasonal sustain­ability. The urban shift towards nucle­ar families has spurred a growing de­mand for companion animals like dogs and cats, boosting the pet care market. Major corporations, such as Tata and Reliance, are investing heavily in the sector, with initiatives like Tata Trusts' upcoming Small Animal Hospital in Mumbai and Reliance's 'Vantara' ani­mal rescue center in Jamnagar, further stimulating market expansion. How­ever, customers face significant chal­lenges, including limited technical and medical support. Veterinary health­care lags behind human healthcare, with a shortage of clinics, hospitals, and expertise in using medicines and vaccines. Animal owners often depend entirely on veterinary doctors and technicians for medical advice, which can be insufficient for optimal animal care.

Modhike Pharma, headquartered in New Delhi with a manufacturing plant in Dehradun, is a leading pharmaceutical company renowned for its wide range of high-quality human and veterinary pharmaceutical products. Committed to innovation and affordability, the company serves global markets with its diverse portfolio, embodying a mission of caring for society's health needs.

Advancing Animal Health through Innovation

Since its inception in 2014, Modhike Veterinary Division has achieved significant milestones driven by a deep-seated commitment to animal welfare and ecosystem preservation. Initially launching with just five products, the company has expanded its range to over 150 SKUs catering to various animal species, from pets to livestock, over the past decade. Recognizing the flourishing market for pets in India, the firm is now embarking on developing a new range of companion animal products at affordable prices intended for over-the-counter sales. This expansion underscores the company's dedication to meeting evolving market needs while maintaining a focus on accessibility and affordability. The finished products are exported to African continent, Central Asia, and Middle East. Through its philanthropic ethos and understanding of the interconnectedness of ecosystems, Modhike continues to make strides in advancing animal health and contributing to broader public health initiatives, exemplifying its commitment to sustainable growth and societal impact. “A medicine heals human, while a veterinary medicine heals humanity”, says Harish Ramchandani, Managing Director.

Transforming Veterinary Care Through Cutting-Edge Solutions

Modhike is a dynamic pharmaceutical company renowned for its extensive range of high-quality products and services. Specializing in both human and veterinary pharmaceuticals, the firm offers a diverse portfolio, including tablets, capsules, liquid orals, injections, powders, suspensions, creams, ointments, and eye drops. Committed to innovation and affordability, the firm relentlessly works to develop and produce life-saving medicines, serving patients, healthcare professionals, and business partners globally. Modhike’s client engagement process begins by selecting reputable distributors with extensive networks, both domestically and internationally. These distributors are chosen based on their ability to market Modhike's products and provide technical support to ensure optimal results and efficacy for end users. The company continuously gathers customer feedback and develops new products in response to market demands and requirements, providing a responsive and effective engagement cycle from understanding client needs to delivering services. "Modhike has notably improved animal health through its acclaimed range of nutritional medicines, available in both injectables and oral forms for livestock and poultry”, says Harish Ramchandani.

Recognizing the essential role of nutrition and health in animal growth and well-being, Modhike emphasizes nutrition, hygiene, and timely vaccination. Moreover, maintaining quality in veterinary medicines is crucial for preserving and improving animal health. The firm ensures its products meet industry standards through a state-of-the-art manufacturing facility in Uttarakhand, accredited with WHO and GMP certifications. The firm has an in-house Quality Control Laboratory and an independent Quality Assurance department to identify and address any gaps in guidelines. Regular factory inspections are conducted, providing opportunities for continuous improvement and stringent quality control at each manufacturing stage. The firm employs effective sustainability methods in manufacturing to benefit both the animal community and mankind. The facility houses an Effluent Treatment Plant with a five-stage purification process for recycling water waste and a fully functional rainwater harvesting system. Secondary packaging is made of recyclable paper, minimizing environmental harm. The company reduces plastic usage in its products and collaborates with government-approved waste disposal agencies to recycle plastic and aluminum waste, enhancing overall sustainability in the manufacturing process. These efforts have been praised by customers for effectively preventing major outbreaks and safeguarding animals against various diseases, showcasing the significant impact of their veterinary medicines. The firm boasts a diverse team of professionals with extensive expertise in both human and veterinary medicine manufacturing and marketing. This breadth of experience enables the company to pursue a business-to-customer model, ensuring cost-effective end products and bolstering customer confidence in the brand.

Modhike is poised for expansion, with plans to establish a new R&D facility dedicated to veterinary medicines. Additionally, the company is exploring opportunities to incorporate a new veterinary vaccine manufacturing facility. With state-of-the-art facilities and a dedicated R&D division, the company strives to fulfill its vision of becoming a world-class player in the pharmaceutical industry while upholding its mission of caring for society and promoting health and well-being.